home / stock / lxg:cc / lxg:cc news

LXG:CC News and Press, Lexagene Holdings Inc. From 07/27/22

Stock Information
Company Name: Lexagene Holdings Inc.
Stock Symbol: LXG:CC
Market: TSXVC
Menu
LXG:CC LXG:CC Quote LXG:CC Short LXG:CC News LXG:CC Articles LXG:CC Message Board
Get LXG:CC Alerts

News, Short Squeeze, Breakout and More Instantly...
LXG:CC - LexaGene Completes Multi-Center Validation Study Using MiQLab® System for Diagnosing Urinary Tract Infections

BEVERLY, Mass., July 27, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc. , ( OTCQB: LXXGF ; TSX-V: LXG ) (“LexaGene” or the “Company”), a molecular diagnostics company that has commercialized the MiQLab® System for automated PCR-based s...
LXG:CC - LexaGene Provides MCTO Update

BEVERLY, Mass., July 12, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc. , ( OTCQB: LXXGF ; TSX-V: LXG ) (“LexaGene” or the “Company”), a molecular diagnostics company that has commercialized the MiQLab® System for automated PCR-based s...

LXG:CC - LexaGene Announces Webinar by UC Davis Professor on Use of MiQLab® System for Diagnosis of Urinary Tract Infections

BEVERLY, Mass., July 05, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc. , ( OTCQB: LXXGF ; TSX-V: LXG ) (“LexaGene” or the “Company”), a molecular diagnostics company that has commercialized the MiQLab System for automated, multiplexing PCR...

LXG:CC - LexaGene Announces MiQLab® System Sale to Veterinary Hospital in Wisconsin

BEVERLY, Mass., July 01, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc. , ( OTCQB: LXXGF ; TSX-V: LXG ) (“LexaGene” or the “Company”), a molecular diagnostics company that has commercialized the MiQLab® System for automated, multiplexi...
LXG:CC - LexaGene Announces Management Cease Trade Order

BEVERLY, Mass., June 30, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc. , ( OTCQB: LXXGF ; TSX-V: LXG ) (“LexaGene” or the “Company”) announces, further to its news release on June 28, 2022, the Company has been granted a management cease trade...

LXG:CC - LexaGene Files Form 10 Registration Statement with the SEC and Announces a Delay in Filing Year-End Annual Canadian Financial Filings

BEVERLY, Mass., June 28, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings Inc. (OTCQB: LXXGF; TSX-V: LXG) (“ LexaGene ” or the “ Company ”) announces that it has filed an initial registration statement with the United States Securities and Exchange Commission (...

LXG:CC - LexaGene Announces Multi-System Purchase from a Large Market Leader in Animal Health

BEVERLY, Mass., May 25, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc. , ( OTCQB: LXXGF ; TSX-V: LXG ) (“LexaGene” or the “Company”), a molecular diagnostics company that has commercialized an instrument for automated multiplex PCR testing, is ...
LXG:CC - LexaGene Successfully Completes CRADA with US Army

BEVERLY, Mass., May 03, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc. , ( OTCQB: LXXGF ; TSX-V: LXG ) (“LexaGene” or the “Company”), a molecular diagnostics company that has commercialized the MiQLab® System , a fully automated r...

LXG:CC - LexaGene Announces Multi-System Purchase from a Corporate Veterinary Reference Laboratory

BEVERLY, Mass., April 25, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc. , ( OTCQB: LXXGF ; TSX-V: LXG ) (“LexaGene” or the “Company”), a molecular diagnostics company that has commercialized an instrument for automated multiplex PCR testing, i...

LXG:CC - LexaGene Announces Advancements to its Sample Preparation Cartridge for the Veterinary Market

BEVERLY, Mass., March 29, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings Inc. , ( TSX-V: LXG ; OTCQB: LXXGF ) (the “ Company ”), a molecular diagnostics company that has commercialized the MiQLab® System , a fully automated rapid pathogen testing devi...
Previous 10 Next 10